Your browser doesn't support javascript.
loading
Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
Drain, P K; Kleene, J M; Coleman, S M; Losina, E; Katz, J N; Giddy, J; Ross, D; Freedberg, K A; Bassett, I V.
Affiliation
  • Drain PK; Massachusetts General Hospital, Boston, MA, USA.
  • Kleene JM; Stony Brook School of Medicine, Stony Brook, NY, USA.
  • Coleman SM; Boston University School of Public Health, Boston, MA, USA.
  • Losina E; Massachusetts General Hospital, Boston, MA, USA.
  • Katz JN; Harvard Medical School, Boston, MA, USA.
  • Giddy J; Brigham and Women's Hospital, Boston, MA, USA.
  • Ross D; McCord Hospital, Durban, South Africa.
  • Freedberg KA; St Mary's Hospital, Durban, South Africa.
  • Bassett IV; Massachusetts General Hospital, Boston, MA, USA.
HIV Med ; 16(10): 640-4, 2015 Nov.
Article in En | MEDLINE | ID: mdl-25958770
ABSTRACT

OBJECTIVES:

The World Health Organization (WHO) recommends screening HIV-infected people for cryptococcal antigens to identify cryptococcosis, a major cause of AIDS-related deaths. As the burden of cryptococcosis is unknown in South Africa's KwaZulu-Natal province, we assessed the cryptococcal antigenuria prevalence among newly diagnosed HIV-infected adults there.

METHODS:

We conducted a cross-sectional study of newly diagnosed HIV-infected adults who received voluntary HIV testing in an out-patient clinic. Participants provided a urine specimen in a sterile container, and we performed testing with a WHO-endorsed rapid cryptococcal antigen lateral flow assay (Immy Inc., Norman, OK, USA) per the manufacturer's specifications. We assessed cryptococcal antigenuria prevalence among participants with CD4 counts < 200 cells/µL, and stratified results by CD4 count categories.

RESULTS:

Among 432 participants, the mean (± standard deviation) age was 36.1 ± 9.9 years and 172 (40%) were female. The overall estimated prevalence of cryptococcal antigenuria was 9.0% [95% confidence interval (CI) 6.5-12.1%]. CD4 counts were available for 319 participants (74%); the median CD4 count was 75 cells/µL [interquartile range (IQR) 34-129 cells/µL]. Participants with a negative cryptococcal antigenuria screening test had a median CD4 count of 79 cells/µL (IQR 36-129 cells/µL), while participants with a positive cryptococcal test had a median CD4 count of 41 cells/µL (IQR 10-112 cells/µL). The estimated prevalence of cryptococcal antigenuria among participants with CD4 counts < 50 cells/µL was 12.5% (95% CI 7.0-20.1%), which was significantly higher than that among participants with CD4 counts of 50-200 cells/µL (4.8%; 95% CI 2.3-8.7%).

CONCLUSIONS:

Nearly 1 in 10 newly diagnosed HIV-infected adults with CD4 counts < 200 cells/µL in KwaZulu-Natal had evidence of cryptococcal antigenuria. Point-of-care CD4 count testing and cryptococcal antigen screening may rapidly identify cryptococcosis at the time of HIV diagnosis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / AIDS-Related Opportunistic Infections / Cryptococcosis / Cryptococcus / Antigens, Fungal Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2015 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / AIDS-Related Opportunistic Infections / Cryptococcosis / Cryptococcus / Antigens, Fungal Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: HIV Med Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2015 Type: Article Affiliation country: United States